000 | 01686 a2200493 4500 | ||
---|---|---|---|
005 | 20250517081310.0 | ||
264 | 0 | _c20161103 | |
008 | 201611s 0 0 eng d | ||
022 | _a1998-4138 | ||
024 | 7 |
_a10.4103/0973-1482.154937 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJia, X Q | |
245 | 0 | 0 |
_aNodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients. _h[electronic resource] |
260 |
_bJournal of cancer research and therapeutics _c |
||
300 |
_a740-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBreast Neoplasms _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymph Nodes _xmetabolism |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Grading |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xmetabolism |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPostmenopause |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptors, Estrogen _xmetabolism |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aHong, Q | |
700 | 1 | _aCheng, J Y | |
700 | 1 | _aLi, J W | |
700 | 1 | _aWang, Y J | |
700 | 1 | _aMo, M | |
700 | 1 | _aShao, Z M | |
700 | 1 | _aShen, Z Z | |
700 | 1 | _aLiu, G Y | |
773 | 0 |
_tJournal of cancer research and therapeutics _gvol. 11 _gno. 4 _gp. 740-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4103/0973-1482.154937 _zAvailable from publisher's website |
999 |
_c25737267 _d25737267 |